Devin Abrahami

Devin Abrahami is a pharmacoepidemiologist specializing in the comparative safety and effectiveness of medications for chronic diseases. With a PhD in Epidemiology from McGill University and ongoing postdoctoral studies at Harvard Medical School, Devin has focused on cancer pharmacoepidemiology and causal inference methods. Previous roles include managing research initiatives at iMD Research and serving as an RWD scientist at RW Analytica, where Devin advanced real-world evidence methodologies. Additionally, Devin has contributed to academic research at Brigham and Women's Hospital and Western University, nurturing a passion for impactful evidence generation in healthcare.